Tamsulosin in men with confirmed bladder outlet obstruction: a clinical and urodynamic analysis from a single centre in New Zealand
Open Access
- 1 January 2001
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 87 (1) , 24-31
- https://doi.org/10.1046/j.1464-410x.2001.00983.x
Abstract
Objective To evaluate the clinical and pressure‐flow effects of tamsulosin 0.4 mg once daily in patients with lower urinary tract symptoms (LUTS) caused by benign prostatic obstruction (BPO), as doc...Keywords
This publication has 17 references indexed in Scilit:
- ??-Adrenoceptor Antagonists in the Treatment of Benign Prostatic HyperplasiaDrugs, 1999
- A SECOND PHASE III MULTICENTER PLACEBO CONTROLLED STUDY OF 2 DOSAGES OF MODIFIED RELEASE TAMSULOSIN IN PATIENTS WITH SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 1998
- alpha 1-ADRENERGIC RECEPTOR SUBTYPES IN HUMAN DETRUSORJournal of Urology, 1998
- Long-Term Evaluation of Tamsulosin in Benign Prostatic Hyperplasia: Placebo-Controlled, Double-Blind Extension of Phase III TrialUrology, 1998
- Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic HyperplasiaUrology, 1998
- Medical therapy and quality of life.European Urology, 1998
- Clinical comparison of selective and non‐selective &agr;1A‐adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing dosesBritish Journal of Urology, 1997
- Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia)British Journal of Urology, 1997
- The effects of tamsulosin, a high affinity antagonist at functional α1A‐ and α1D‐adrenoceptor subtypesBritish Journal of Pharmacology, 1997
- Tamsulosin, a selective α1c‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)British Journal of Urology, 1995